The acquisition of 3P innovation's RFF Cell enables Dalton to address larger segments of the pharmaceutical market and serve customers with greater global patient populations. TORONTO — Pharmaceutical ...

In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...

A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products. TORONTO, March 31, 2026 /PRNewswire/ ...

Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.

Isolator-based Grade A/ISO 5 architectures minimize operator interventions, enabling robust contamination control and compliance with EU GMP Annex 1, FDA guidance, PIC/S, and ISO 14644. Lyophilization ...